Skip to main content

Posts

Steroids in Spinal Cord Injury

 The use of steroids, particularly high-dose methylprednisolone (MP), in the treatment of acute spinal cord injury (SCI) has been extensively studied and remains a topic of debate. The primary goal of administering steroids post-injury is to mitigate secondary damage by reducing inflammation and oxidative stress. However, the efficacy and safety of this approach have been questioned. Key Clinical Trials and Findings: National Acute Spinal Cord Injury Study (NASCIS) II (1990): This randomized controlled trial evaluated the effects of high-dose MP administered within 8 hours of injury. A subgroup analysis suggested a modest improvement in motor function scores for patients treated within this time frame. However, the clinical significance of this improvement has been debated, and concerns about methodological limitations were raised. TheNNT NASCIS III (1997): This study compared 24-hour and 48-hour MP infusion protocols. The results did not demonstrate a significant benefit in neur...
Post a Comment
Read more
Recent posts

FINISHER Trial

As of January 2025, the FINISHER (Fight INflammation to Improve Outcome after aneurysmal Subarachnoid HEmorRhage) trial is ongoing, and its final results have not yet been published. Place: Berlin, Germany The study is designed to assess whether dexamethasone, an anti-inflammatory glucocorticoid, can improve outcomes in patients who have suffered an aneurysmal subarachnoid hemorrhage (aSAH). T he trial is a multicenter, prospective, randomized, double-blinded, placebo-controlled phase III study. It plans to enroll 334 patients, who will be randomized to receive either dexamethasone or a placebo within 48 hours after the hemorrhage.  The dexamethasone regimen consists of 8 mg three times daily for the first seven days, followed by 8 mg once daily from days eight to twenty-one.  The primary outcome measure is the modified Rankin Scale (mRS) at six months, dichotomized to favorable (mRS 0-3) versus unfavorable (mRS 4-6) outcomes. Source: Pub Med and Clinical Trials.gov.in  G...
Post a Comment
Read more

Lignocaine Associated Systemic Toxicity (LAST)

  Lidocaine Associated Systemic Toxicity (LAST) Lidocaine Associated Systemic Toxicity (LAST) is a potentially life-threatening condition that occurs due to the excessive absorption of local anesthetics, particularly lidocaine, into the systemic circulation. LAST can result from inadvertent intravascular injection, overdose, or rapid absorption from highly vascularized areas.   Pathophysiology: Lidocaine, like other local anesthetics, works by blocking sodium channels, inhibiting the initiation and propagation of nerve impulses. However, when systemic levels of lidocaine become excessively high, these sodium channels are blocked in vital organs such as the heart and brain, leading to serious complications. Clinical Presentation: LAST can manifest with a variety of symptoms that often progress through two stages: Neurological Symptoms : Early signs include circumoral numbness, metallic taste, tinnitus, and dizziness. As toxicity increases, more severe symptoms such as seizures,...
Post a Comment
Read more

CRASH-3 TRIAL (Tranexamic Acid in Head Injury)

 
Post a Comment
Read more

SALSA Trial

The "Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia:  The SALSA Randomized Clinical Trial" published in JAMA, is a significant clinical trial that specifically investigated the use of slow continuous infusion therapies of hypertonic saline with fast bolus replacement, for patients with symptomatic hyponatremia.  Background:   Symptomatic hyponatremia is a condition in which patients have low sodium levels in the blood, leading to neurological symptoms and potentially life-threatening complications. Rapid correction of sodium levels is necessary in such cases to alleviate symptoms and prevent harm. Objective:   The SALSA trial aimed to assess the efficacy and safety of two different strategies for correcting symptomatic hyponatremia using hypertonic saline solutions.  Methods: The study was a randomized clinical trial involving patients with symptomatic hyponatremia. Participants were divided into two groups:...
Post a Comment
Read more

BLUNT TRAUMA TO EYE VARIOUS FINDINGS

Blunt trauma to the eye can result in a wide range of findings and injuries, depending on the force and direction of the impact. The Trauma can be due to Direct Injury Contre-coup Injury Shearing forces and shock waves. The eye is a delicate organ with several components, and trauma can result into open or closed globe injuries. Following are some of the findings and injuries commonly associated with blunt trauma to different components of the eye:         Eyelids and Surrounding Tissues: ü   Contusions and bruising of the eyelids and periorbital area. May give an appearance of Raccoon Eyes. ü   Lacerations or cuts on the eyelids. ü   Swelling and edema of the eyelids.         Conjunctiva: ü   Subconjunctival hemorrhage, which appears as redness on the white part of the eye. ü   Chemosis, which is swelling of the conjunctiva.         Cornea: ü ...
Post a Comment
Read more

MOPETT Trial (Multicenter Observational Study of Pulmonary Embolism Thrombolysis)-2013

  MOPETT trial (Multicenter Observational Study of Pulmonary Embolism Thrombolysis)  was a randomized controlled trial that evaluated the efficacy and safety of low-dose thrombolysis in patients with acute intermediate-risk pulmonary embolism (PE).  The trial included 121 patients who were randomly assigned to receive either low-dose alteplase (50 mg) or low-dose heparin plus placebo.  The primary endpoint of the trial was the development of pulmonary hypertension at 28 months. The secondary endpoints were recurrent PE at 28 months and major bleeding events.  The results of the trial showed that  l ow-dose alteplase significantly reduced the risk of developing pulmonary hypertension at 28 months compared to low-dose heparin plus placebo (28% vs. 56%) . There was no significant difference between the two groups in the risk of recurrent PE or major bleeding events.  The MOPETT trial provides evidence that low-dose thrombolysis is an effect...
Post a Comment
Read more